Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Closing Bell 8 September

Grady Wulff
September 8, 2022

Morning Bell 8 September

Grady Wulff
September 8, 2022

Closing Bell 7 September

Grady Wulff
September 7, 2022

Morning Bell 7 September

Sophia Mavridis
September 7, 2022

Closing Bell 6 September

Paulina Peters
September 6, 2022

Preparing for your retirement

Bell Direct
September 6, 2022

Deciding on your SMSF Structure

Bell Direct
September 6, 2022

Contributing to Super

Bell Direct
September 6, 2022

What’s involved with an SMSF

Bell Direct
September 6, 2022

Morning Bell 6 September

Paulina Peters
September 6, 2022

Closing Bell 5 September

Grady Wulff
September 5, 2022

Morning Bell 5 September

Grady Wulff
September 5, 2022